The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 30, 2026

Filed:

Apr. 08, 2020
Applicant:

Wake Forest University Health Sciences, Winston-Salem, NC (US);

Inventors:

Dawen Zhao, Winston-Salem, NC (US);

Yang Liu, Winston-Salem, NC (US);

Neil William Crowe, Winston-Salem, NC (US);

Assignee:

Wake Forest University Health Sciences, Winston-Salem, NC (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/7084 (2006.01); A61K 9/00 (2006.01); A61K 9/127 (2025.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7084 (2013.01); A61K 9/0073 (2013.01); A61K 9/127 (2013.01); A61K 39/3955 (2013.01);
Abstract

Compositions containing lipid nanoparticles and nucleic acid therapeutic agents are disclosed. For example, calcium phosphate nanoparticles having a lipid coating are provided, wherein the calcium phosphate nanoparticles include a cyclic dinucleotide and the lipid coating includes phosphatidylserine. The compositions can be formulated for administration to the lungs of a subject via inhalation, or for administration via injection. Methods for the treatment of lung cancer and other cancers are also described. Targeted delivery of therapeutic agents such as cyclic dinucleotides to antigen presenting immune cells via the disclosed methods can elicit beneficial antitumor immunity.


Find Patent Forward Citations

Loading…